News | April 12, 2026
Eli Lilly launches once-daily weight-loss pill Foundayo
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
The event also featured discussions on emerging trends in joint replacement surgery
The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
The approval clears the way for a US study at leading clinical centers to evaluate the safety and effectiveness of VDYNE’s system in patients
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
The new single-pill therapy combines cilnidipine, telmisartan and metoprolol, bringing together three established antihypertensive agents with complementary mechanisms
The Abbreviated New Drug Application with FDA covers multiple strengths of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets
The enhanced allocation will be directed toward expanding healthcare infrastructure, increasing patient capacity, and widening acces
The initiative aligns with global psycho-oncology standards that advocate routine distress screening as a core quality benchmark in cancer treatment
Subscribe To Our Newsletter & Stay Updated
